Kore Private Wealth LLC Takeda Pharmaceutical CO LTD Transaction History

Kore Private Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $43,065 - $53,627	-3,270 Reduced 23.13%	10,866 $148,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $230,416 - $243,987	14,136 New	14,136 $232,000
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $39,330 - $44,137	-2,300 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $2,159 - $2,886	-148 Reduced 6.05%	2,300 $41,000
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $7,616 - $11,881	585 Added 31.4%	2,448 $37,000

Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $31,447 - $38,806	1,863 New	1,863 $37,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $12,352 - $15,265	-745 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$16.7 - $21.52 $12,441 - $16,032	745 New	745 $15,000

340

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.